Reversibility of regorafenib effects in hepatocellular carcinoma cells.
about
Targeting gastrointestinal stromal tumors: the role of regorafenibRegorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy ModelsEfficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access ProgramAntagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.Modulation of Regorafenib effects on HCC cell lines by epidermal growth factorResistance to multikinase inhibitor actions mediated by insulin like growth factor-1IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.
P2860
Q26747162-DFC7F1D3-5187-4F71-AB62-3CED6EE760DEQ27345024-A3613FDB-D95D-4D5B-BC38-5400D29318EAQ33584090-66E55AC4-CDDD-49D2-B303-E441DCBAE462Q33684043-500D3EEE-47B4-4784-9E05-397F53BC8A0EQ35639692-0D237A92-FA38-4EC8-94FD-C43B4729F13BQ36019476-98DF8EDB-A50E-41B6-B34A-A448CD44C211Q47101174-B592FAD2-737E-478A-BE96-DC13CC7DC906
P2860
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@en
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@nl
type
label
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@en
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@nl
prefLabel
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@en
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
@nl
P2093
P2860
P1476
Reversibility of regorafenib effects in hepatocellular carcinoma cells
@en
P2093
Aldo Cavallini
Antonio Di Carlo
Caterina Messa
Catia Lippolis
Maria G Refolo
Roberta Rossi
Rosalba D'Alessandro
P2860
P2888
P304
P356
10.1007/S00280-013-2269-8
P577
2013-10-01T00:00:00Z